Convergence Investment Partners, LLC
Source: SEC Form 13F · as of Mar 2026Convergence Investment Partners, LLC holds 24 biotech & pharma companies tracked by BioSniper, totaling $63.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
24
Total value held
$63.1M
| Company | Shares | Value |
|---|---|---|
| BMYBRISTOL MYERS SQUIBB CO | 136,384 | $8.3M |
| MRKMerck & Co., Inc. | 46,800 | $5.6M |
| CAHCardinal Health Inc. | 21,372 | $4.5M |
| ABBVAbbVie Inc. | 19,873 | $4.3M |
| GILDGILEAD SCIENCES, INC. | 29,860 | $4.2M |
| JNJJOHNSON & JOHNSON | 16,301 | $4.0M |
| PMPhilip Morris International Inc | 22,756 | $3.8M |
| INCYIncyte Corp. | 31,020 | $2.9M |
| JAZZJazz Pharmaceuticals plc | 15,285 | $2.9M |
| GMOptec International, Inc. | 37,454 | $2.8M |
| BIIBBIOGEN INC. | 13,557 | $2.5M |
| CORCencora Inc. | 7,789 | $2.4M |
| HALOHALOZYME THERAPEUTICS, INC. | 37,599 | $2.4M |
| MCKMcKesson Corporation | 2,521 | $2.2M |
| GMEDGlobus Medical Inc. | 25,132 | $2.2M |
| CPRXCATALYST PHARMACEUTICALS, INC. | 75,682 | $1.9M |
| PTCTPTC THERAPEUTICS, INC. | 27,219 | $1.9M |
| OSCROscar Health Inc. | 105,336 | $1.2M |
| VTRSViatris Inc | 75,204 | $1.0M |
| LLYELI LILLY & Co | 747 | $687K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,272 | $615K |
| PFEPFIZER INC | 11,140 | $313K |
| AMGNAMGEN INC | 885 | $311K |
| ABTABBOTT LABORATORIES | 2,175 | $223K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.